Common Stock, Shares, Issued of MUSTANG BIO, INC. from 31 Dec 2015 to 30 Jun 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
MUSTANG BIO, INC. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2015 to 30 Jun 2023.
  • MUSTANG BIO, INC. Common Stock, Shares, Issued for the quarter ending 30 Jun 2023 was 7,320,444, a 93% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

MUSTANG BIO, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 7,320,444 -97,190,751 -93% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 7,293,242 -92,994,596 -93% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 7,100,111 -86,482,880 -92% 31 Dec 2022 10-Q 14 Aug 2023 2023 Q2
Q3 2022 106,427,767 +15,267,953 +17% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 104,511,195 +14,575,033 +16% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 100,287,838 +15,244,685 +18% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 93,582,991 +22,662,298 +32% 31 Dec 2021 10-Q 14 Nov 2022 2022 Q3
Q3 2021 91,159,814 +30,995,275 +52% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 89,936,162 +35,109,919 +64% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 85,043,153 +42,966,313 +102% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 70,920,693 +31,517,174 +80% 31 Dec 2020 10-Q 12 Nov 2021 2021 Q3
Q3 2020 60,164,539 +20,586,168 +52% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 54,826,243 +15,371,927 +39% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 42,076,840 +14,515,407 +53% 31 Mar 2020 10-Q 11 May 2020 2019 Q1
Q4 2019 39,403,519 +12,793,336 +48% 31 Dec 2019 10-K 24 Mar 2021 2020 FY
Q3 2019 39,578,371 +13,314,740 +51% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 39,454,316 +13,190,962 +50% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 27,561,433 +1,459,879 +5.6% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 26,610,183 +1,373,928 +5.4% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 26,263,631 +1,031,492 +4.1% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 26,263,354 +1,041,465 +4.1% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 26,101,554 +1,059,665 +4.2% 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 25,236,255 +10,071,011 +66% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 25,232,139 +14,269,436 +130% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 25,221,889 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 25,041,889 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 15,165,244 +13,165,244 +658% 31 Dec 2016 10-K 29 Mar 2018 2017 FY
Q3 2016 10,962,703 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q4 2015 2,000,000 31 Dec 2015 10-K 31 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.